Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes

被引：8
|
作者：
Uno, Hajime [1 ,2 ]
Horiguchi, Miki [1 ]
Hassett, Michael J. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
来源：
ONCOLOGIST | 2020年 / 25卷 / 02期
关键词：
Interpretability; Robustness; Survival data analysis; Test; estimation coherency; Treatment decision making; MEAN SURVIVAL-TIME; HAZARD RATIO;
D O I：
10.1634/theoncologist.2019-0464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91 / 93
页数：3
相关论文
共 50 条
  • [1] Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology
    Horiguchi, Miki
    Hassett, Michael J.
    Uno, Hajime
    [J]. CLINICAL TRIALS, 2020, 17 (06) : 597 - 606
  • [2] On the estimation of intracluster correlation for time-to-event outcomes in cluster randomized trials
    Kalia, Sumeet
    Klar, Neil
    Donner, Allan
    [J]. STATISTICS IN MEDICINE, 2016, 35 (30) : 5551 - 5560
  • [3] Transportability Methods for Time-to-Event Outcomes: Application in Adjuvant Colon Cancer Trials
    Zuo, Shuozhi
    Josey, Kevin P.
    Raghavan, Sridharan
    Yang, Fan
    Juarez-Colunga, Elizabeth
    Ghosh, Debashis
    [J]. JCO CLINICAL CANCER INFORMATICS, 2022, 6 : e2200088
  • [4] Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment
    Weir, I. R.
    Marshall, G. D.
    Schneider, J. I.
    Sherer, J. A.
    Lord, E. M.
    Gyawali, B.
    Paasche-Orlow, M. K.
    Benjamin, E. J.
    Trinquart, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (01) : 96 - 102
  • [5] Guidelines for time-to-event endpoints' definitions in cancer randomized controlled trials (RCTs) for breast cancer - results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
    Gourgou-Bourgade, S.
    Dabakuyo-Yonli, S.
    Cameron, D.
    Cardoso, F.
    Poortmans, P.
    Asselain, B.
    Azria, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S441 - S442
  • [6] Discussion on 'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'
    Xi, Dong
    Bretz, Frank
    [J]. BIOMETRICAL JOURNAL, 2022, 64 (02) : 243 - 245
  • [7] A proportional risk model for time-to-event analysis in randomized controlled trials
    Kuss, Oliver
    Hoyer, Annika
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (02) : 411 - 424
  • [8] An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology
    Dodd, Lori E.
    Korn, Edward L.
    Freidlin, Boris
    Gu, Wenjuan
    Abrams, Jeffrey S.
    Bushnell, William D.
    Canetta, Renzo
    Doroshow, James H.
    Gray, Robert J.
    Sridhara, Rajeshwari
    [J]. CLINICAL TRIALS, 2013, 10 (05) : 754 - 760
  • [9] Rejoinder for discussions on correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials
    Liu, Yi
    Wang, Bushi
    Tian, Hong
    Hsu, Jason C.
    [J]. BIOMETRICAL JOURNAL, 2022, 64 (02) : 246 - 255
  • [10] Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials
    Weir, Isabelle R.
    Rider, Jennifer R.
    Trinquart, Ludovic
    [J]. PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 163 - 175
12345